Colorectal Cancer Test Use from the 2005 National Health Interview Survey
- 1 July 2008
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 17 (7) , 1623-1630
- https://doi.org/10.1158/1055-9965.epi-07-2838
Abstract
Background: Screening is effective in reducing colorectal cancer mortality. Recommended colorectal cancer screening options include a home fecal occult blood test (FOBT) or colorectal endoscopy (sigmoidoscopy or colonoscopy). Past surveys have indicated that colorectal cancer screening prevalence in the United States is low. The purpose of this analysis was to determine the prevalence of colorectal cancer test use in the United States by various factors and to examine reasons for not having a colorectal cancer test.Keywords
This publication has 31 references indexed in Scilit:
- Underuse of colorectal cancer screening in a cohort of medicare beneficiariesCancer, 2007
- Reported drop in mammographyCancer, 2007
- Colorectal cancer prevention: Adherence patterns and correlates of tests done for screening purposes within United States populationsCancer Detection Prevention, 2006
- Trends in colon cancer screening procedures in the US Medicare and Tricare populations: 1999–2001Preventive Medicine, 2006
- Patterns of Colorectal Cancer Screening Uptake among Men and Women in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2006
- Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidenceGastroenterology, 2003
- Randomised study of screening for colorectal cancer with faecal-occult-blood testThe Lancet, 1996
- Randomised controlled trial of faecal-occult-blood screening for colorectal cancerThe Lancet, 1996
- Concordance of Self-reported Data and Medical Record Audit for Six Cancer Screening ProceduresJNCI Journal of the National Cancer Institute, 1993
- Patients as Reliable Reporters of Medical Care ProcessMedical Care, 1992